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Several considerations prompt investigative dermatologists to
study rosacea: it is common; its etiology remains unknown;
its pathophysiology is poorly understood; and it has a
significant impact on quality of life, all of which leave
considerable space for investigation. Rosacea includes
several distinct clinical subtypes, which lead to questions
addressed by research that takes advantage of several of the
disciplines within experimental dermatology, including im-
munology, inflammation, neuroimmunology, neuroscience,
matrix biology and fibrosis, genetics, and vascular biology.
Although epidemiological studies favor a genetic component
in rosacea, no ‘‘rosacea predisposing’’ gene(s) have been identi-
fied. Rosacea can be triggered by any one of several environ-
mental ‘‘insults’’, including UVR, spicy foods, alcohol, ‘‘stress’’,
exercise, and temperature change, just to name a few. As a
facial, chronic disease, rosacea has been characterized as having
different clinical and histopathological expressions. These
include erythema (vasodilation), telangiectasia, lymphedema,
lympho-monocytic infiltrates with occasional appearance of
neutrophils, and as a late stage, fibrosis. The pathophysiology of
rosacea appears to be complex, as virtually all cutaneous cells,
including immune cells, appear to have roles. Ultimately,
rosacea is a good ‘‘model’’ through which investigators can
learn more about the complexities of neuroimmune commu-
nication, inflammation, and immunity, as well as about chronic
inflammation and the development of fibrosis.
Indeed, accumulating evidence now leads to the conclu-
sion that in chronic inflammatory diseases, there is close
molecular and cellular interaction among innate immune
defense mechanisms, innervation, immunity, and vascular
biology. Ultimately, treatment is an important goal, and it is
revealing to acknowledge that none of the several treatments
for rosacea is satisfactory. The aim of this collection of reports
is to focus on understanding each element in its pathogenesis
in order to aid the development of novel treatment strategies
for this and other inflammatory and fibrotic skin diseases.
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